Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2 without changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:30:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1; this appears to be a minor metadata update with no changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:53:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a glossary toggle and QC-related metadata labels (Last Update Submitted that Met QC Criteria) along with a revision tag (Revision: v3.4.0). These are UI/metadata updates rather than changes to core study content.
    Difference
    0.2%
    Check dated 2026-01-28T20:28:12.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision label updated to v3.3.4 and the previous label v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:52:14.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added new study locations across Australia, New Zealand, and Germany and removed some prior location entries.
    Difference
    0.9%
    Check dated 2025-12-23T20:40:50.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A minor wording update in the Publications section clarifies that publications are provided voluntarily by the person entering information and relate to the study results, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:31:15.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.